Embecta (EMBC) is a global medical device company that focuses on providing solutions to people living with diabetes. CEO, Dev Kurdikar discusses the outlook for the company. He talks about how EMBC is one of the leading manufacturers of pen needles and he estimates that 30M people around the world use them. EMBC produces almost 8B units per year and the company has been in business for almost 100 years. He then goes over what's next for EMBC. Tune in to find out more about EMBC and the stock market today.
01 Nov 2022
Market On Close
22 Feb 2023
Morning Trade Live
14 Feb 2023
Morning Trade Live
05 Jan 2023
Trading 360
06 Jan 2023
The Watch List
20 Jan 2023
Trading 360
10 Feb 2023